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Abstract
Introduction: Snakebite accidents are an important health problem in rural areas of tropical countries worldwide, including
Costa Rica, where most bites are caused by the pit-viper Bothrops asper. The treatment of these potentially fatal accidents is
based on the timely administration of specific antivenom. In many regions of the world, insufficient health care systems and
lack of antivenom in remote and poor areas where snakebites are common, means that efficient treatment is unavailable for
many snakebite victims, leading to unnecessary mortality and morbidity. In this study, geographical information systems
(GIS) were used to identify populations in Costa Rica with a need of improved access to antivenom treatment: those living in
areas with a high risk of snakebites and long time to reach antivenom treatment.
Method/Principal Findings: Populations living in areas with high risk of snakebites were identified using two approaches:
one based on the district-level reported incidence, and another based on mapping environmental factors favoring B. asper
presence. Time to reach treatment using ambulance was estimated using cost surface analysis, thereby enabling adjustment
of transportation speed by road availability and quality, topography and land use. By mapping populations in high risk of
snakebites and the estimated time to treatment, populations with need of improved treatment access were identified.
Conclusion/Significance: This study demonstrates the usefulness of GIS for improving treatment of snakebites. By mapping
reported incidence, risk factors, location of existing treatment resources, and the time estimated to reach these for at-risk
populations, rational allocation of treatment resources is facilitated.
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Introduction
Snakebites are a health problem in several parts of the world
[1], especially affecting poor people living in rural areas in tropical
countries [2]. The treatment of snakebite envenoming is based on
the timely administration of animal-derived antivenoms [3].
However, a number of factors limit the accessibility of antivenoms
in various areas of the world [3,4]. The relatively high cost of some
antivenoms make accessing them difficult in low income countries
[4]. In addition, long distances to healthcare facilities and incorrect
distribution of antivenoms within countries [3,5,6] means that for
many of the snakebite victims worldwide, specific treatment with
safe and effective antivenoms is unavailable, and traditional
healers are instead often consulted [1,7–9]. This is an unfortunate
situation as antivenom treatment is highly effective at preventing
morbidity and mortality caused by snakebite envenoming [3]. In
other regions of the world, such as in various countries in Latin
America, antivenom is readily available in health centers [5]. This
is the case of Costa Rica, where antivenom is widely available
throughout the public health system, as a result of domestic
production and effective acquisition and distribution schemes [5].
The incidence of snakebites is known to vary widely on a sub-
national level due to environmental and demographic factors [10–
14]. In Central America, an estimated number of 4,000 snakebite
cases occur every year [15]. The Central America lancehead
pitviper Bothrops asper, locally known as ‘terciopelo’ or ‘barba
amarilla’, which is widely distributed in humid, lowland areas (0–
600 m.a.s.l., but it might be found up to 1,200 m.a.s.l.) [16,17], is
responsible for 50–80% of the bites and 60–90% of all fatal cases
in Central America and northern South America [13]. Epidemi-
ological studies indicate that most victims are agricultural workers
and/or rural residents in general [13]. In the 1990s, the snakebite
incidence in Costa Rica was approximately 15 per 100,000
inhabitants per year, with a decreasing trend [14]. Snakebite
mortality has also been reported to decrease in Costa Rica, an
observation attributed to, among other things, improvements in
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the health care system, including better geographical accessibility
to health care facilities [12,18]. The use of first aid interventions
and the attendance to traditional healers for treatment of
snakebites is very limited in Costa Rica, at least among those
seeking hospital treatment [19].
Identification of areas with high snakebite incidence is an
important goal for the design of preventive and therapeutic
interventions aimed at reducing the impact of snakebites. Such
interventions could include educational programs, antivenom
distribution and training of health staff in the management of these
envenomations [4–6]. Similar issues of rational distribution of
treatment and intervention resources are being considered in the
struggle against other neglected tropical diseases, with geograph-
ical information systems (GIS) increasingly being used as a tool for
improved decision-making [20]. Leynaud and Reati [21] de-
scribed the use of the free GIS-software SIGEpi [22] for
identification of areas with a high risk of snakebites and long
distances to healthcare in Argentina. It is necessary to further
extend the use of this methodology in other countries, in order to
get an integrated view of snakebite envenomings on various
regions of the world.
The health care system in Costa Rica is considered well
developed, in terms of geographical accessibility [23] and
insurance coverage [24]. This country has made important
achievements in public health, such as long life expectancy and
low infant mortality rate [24,25]. Antivenom is available in all
clinics and hospitals and, according to a recent decision by the
state social insurance administration that runs all public health
services in the country (Caja Costarricense del Seguro Social,
henceforth CCSS), it can also be distributed to primary health care
teams (Equipos Ba´sicos de Atencio´n Integral en Salud, EBAIS) of
which there are approximately 1 per 5,000 inhabitants [24]. This
opens the possibility to further improve the accessibility to
antivenoms in Costa Rica. However, the distribution of anti-
venoms to EBAIS has to be carefully analyzed, in order to ensure
that mostly EBAIS serving a population with high snakebite risk
and limited access to clinics and hospitals will receive antivenoms.
This will prevent unnecessary wastage of this precious drug by
deploying it to regions where snakebites are infrequent, or where
distances to hospitals or clinics where these accidents are treated
are short.
Objectives
The primary aim of the present study is to provide information
to assist decision-making concerning for which primary health care
facilities (EBAIS) it is suitable to have antivenom, i.e. those that
serve a population with a high risk of snakebites and long transport
times to hospitals or clinics where antivenom is available. The
methodology used in this study might be applied in other countries
and regions where snakebite envenoming is a relevant public
health hazard, in order to identify vulnerable areas that require
interventions aimed at ensuring the access to antivenom and
adequate medical treatment. As part of the primary aim, we will
demonstrate the benefits of spatial smoothing of the small-area
snakebite incidence data for increasing the interpretability of this
data. Aside from the primary aim, we will also describe the
relationship between some district-level environmental and
demographic factors and snakebite incidence in Costa Rica.
Materials and Methods
Outline of the analysis
Populations in a high risk of snakebite were identified using two
approaches: one based on the reported district-level snakebite
incidence, and another based on identifying populations with
environmental and demographic risk factors favoring snakebites.
For the first approach, an incidence of 30 bites per 100,000
population per year was selected as threshold, on the basis of the
overall incidence of snakebite envenomings in Costa Rica (15 cases
per 100,000 inhabitants per year [14]). In order to reduce the
random noise in the small-area incidence, a Bayesian smoothing
method [26] was employed by fitting a Poisson regression to the
observed incidence in the period 2003–2007. Smoothing can be
explained as modelling the underlying risk around which the
observed incidence varies stochastically. As such the smoothed
incidence estimates give a more stable picture of the actual risk of
snakebites than the raw incidence data, making interpretation
easier and giving a better basis for decision-making [26]. Spatial
smoothing was also used by Leynaud and Reati [21] in their study
of snakebite epidemiology in Argentina. In this study, we present
an alternative smoothing method that includes also measured
explanatory variables, and allows for estimation of the probability
that an incidence threshold is exceeded [27]. We then compare the
performance of this smoothing method with the one used by
Leynaud and Reati [21]. Measured variables to be included in the
smoothing were identified in the literature as important factors
influencing snake presence, i.e. environmental factors [16], and
snake-human interaction, in this case urban population percentage
[13].
For the second approach to identifying areas in possible need of
improved antivenom accessibility, rural areas in humid, lowland
areas were considered at high risk of snakebites, as this is a habitat
suitable for the medically most relevant snake species B. asper [16].
Among the populations identified as in high risk of snakebites by
either of these two approaches, those with an estimated minimum
transportation time to hospital or clinic exceeding 2 hours were
identified as those requiring improved antivenom accessibility,
based on the time identified as critical to avoid mortality from
snakebites [13].
Material
The centroid of the census enumeration units were used to
estimate the location of the population [23]. A 2 km buffer around
the census tract centroids were used as a proxy for populated
areas. Census enumeration unit population size in year 2000 and
Author Summary
Snakebite accidents are a neglected cause of much death
and suffering worldwide. The situation is especially severe
in rural areas of low income tropical countries, where long
distances to well-equipped health care facilities mean that
the time needed to reach antivenom treatment is often
long. Delays in receiving antivenom treatment of snake-
bites could lead to severe outcomes, such as death or
permanent disability. In this study we demonstrate how
Geographical Information Systems (GIS) could be used to
allocate antivenom rationally and thereby decrease the
impact of snakebite in a cost-effective manner. We map
areas with a high risk of snakebite accidents, based on a
high reported incidence and environmental conditions
favoring snakebites. We then estimate the time needed to
reach a facility in which antivenom treatment is available
for the population in these high risk areas, thus identifying
areas in need of improved treatment accessibility. Based
on these maps of the unmet need of antivenom treatment,
allocation of antivenom and other resources needed to
treat snakebites can be made more efficiently.
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information whether the unit was urban or rural was available as
attribute information.
Information about snakebite cases 1990–2007 per district of
residence were obtained from hospital discharge reports from the
CCSS. Duplicate cases, with exactly the same age, sex, month of
bite and district of residence (n = 123) were removed from the
analysis. Cases reported from health care facilities in which it was
highly unlikely that the place of the bite was in the district of
residence (n = 141), or when the place of residence was unknown
(n = 43) were also removed. These steps left 9,149 snakebites,
divided over 413 districts (the smallest administrative area)
(Figure 1). The location of B. asper specimens (n = 241) collected
to the serpentarium at Instituto Clodomiro Picado, San Jose´,
Costa Rica was obtained.
Digital maps of environmental variables (elevation 30630 m
raster, mean annual precipitation, number of dry months, forest
coverage, and biotic unit [28]) were obtained from a database
compiled by Instituto Tecnolo´gico de Costa Rica [29]. The values
for each of the environmental variables were extracted to the
census enumeration unit centroids, and the population-weighted
district average value for each of the environmental variables was
calculated. For forest coverage, the proportion of inhabitants living
within 500 meters from forests larger than 5 ha was calculated. A
few districts (n = 9) were covered by clouds in the satellite image
from which the forest coverage was derived, and these were
assigned the mean forest coverage value of the other districts.
The location of lakes, rivers, clinics, hospitals and roads were
obtained from the same database as the environmental variables
[29]. A list of primary health care facilities, i.e. Equipos Ba´sicos de
Atencio´n Integral en Salud (EBAIS) was obtained from the CCSS
[30]. EBAIS were geocoded by matching the name and service
area of the facility with the name and district of communities in
Figure 1. Snakebite incidence per 100,000 inhabitants per district 1990–2007.
doi:10.1371/journal.pntd.0002009.g001
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the country, available as a digital map [29]. In most cases, there
was a community with the same name as the facility. If there was
no such community, the facility was located in the main
community of the district. If it was not possible to determine
which the main community was, the facility was located in one of
the communities located in the center of the service area. Red
Cross ambulance stations were geo-coded using a list and map
available at the Costa Rican Red Cross Website [31].
A Bayesian Poisson regression model of snakebite
incidence
In order to analyze which factors were important for snakebite
occurrence, and to smooth the snakebite incidence, a Bayesian
Poisson regression was used to model the district-level risk of
snakebites. Factors chosen for inclusion were those that had
previously been identified in literature as either influencing snake
presence [16] or important for snake-human interaction patterns
[13]. The number of snakebite cases Y per district i were modeled
as Poisson variates in the form;
YiPoisson(mi)
log mið Þ~az
XK
k~1
bkXizuiz log Yall|
popi
popall
 
where a is the intercept,
PK
k~1
bkXi a matrix of five fixed effect
district-level explanatory variables (urbanity, forest coverage,
elevation, precipitation, and number of dry months), ui a spatially
correlated random effect modelled using a conditional autore-
gressive (CAR) prior structure [32], which assumed dependence
between districts if they shared a border or corner, and
Yall|
popi
popall
correspond to the number of snakebites that would
be expected if they were distributed evenly within the population,
i.e. the offset. In order to facilitate convergence, continuous
variable (precipitation, number of dry months and elevation) were
standardized to have mean 0 and standard deviation 1. The
coefficients for the fixed effects were assigned non-informative
normal distribution priors (mean 0 and precision 0.0001), and the
intercept a non-informative flat prior (range 2‘ to ‘). The
variance of the spatially correlated random effects was assigned a
non-informative gamma prior. The model was fitted in WinBUGS
1.4.3 [33].
When the district-level risk factors of snakebites were analyzed, all
snakebite data (i.e. 1990–2007) were used. Convergence was reached
after 50 000 iterations, after which another 100 000 iterations were
performed to estimate the posterior distribution, from which model
parameters with 95% credible intervals (Cr.I.) were obtained.
Demonstration of spatial smoothing of small-area
snakebite incidence data
The snakebite incidence dataset was divided into nine temporal
periods, six training periods on which the smoothing was
performed, and three test periods used to assess the ability of the
estimates produced by the smoothing methods to improve
identification of future high-incidence districts. Three of the
training periods were five-year periods (1990–1994, 1994–1998
and 1998–2002) and three one-year periods (1994, 1998 and
2002).The three test periods were five years (1995–1999, 1999–
2003 and 2003–2007).
The first smoothing method (A) was the same Bayesian model
with random spatial effects and fixed effect explanatory variables
(elevation, number of dry months, precipitation, forest coverage
and urban population percentage) as described above. The
Bayesian framework makes it possible to estimate the probability
that the incidence exceeds a threshold directly from the posterior
distribution. For each of the training time periods, the models were
run until convergence was reached (after 50,000 iterations) and
then for another 50,000 iterations to obtain samples from the
posterior distribution. From the posterior distribution, the
probability that the incidence exceeded 30 bites per 100,000
inhabitants was calculated.
The second smoothing method (B) was the one used by
Leynaud and Reati [21]; the tool for automated spatial Bayesian
smoothing of incidence rates (‘‘Suavizador espacial de tasas’’)
available in SIGEpi [22]. The settings of local smoothing and
neighborhood defined as adjacency were used.
The abilities of these smoothed estimates, and the unsmoothed
incidence, to identify whether the incidence in a district would
exceed 30 bites per 100,000 in the next-coming five-year period
(i.e. the test periods 1995–1999, 1999–2003 and 2003–2007) were
assessed using the ROC Curve function of IBM SPSS 20 [34].
The AUC (area under the curve) of the ROC (receiver operating
characteristics; a plot of sensitivity vs. one minus specificity) is an
often used tool to assess the discriminatory ability of tests; an AUC
of 0.7–0.9 indicate reasonable discriminatory ability, and .0.9
very good discriminatory ability [35]. For each of the six
combinations of training time (1 and 5 years) and smoothing
method (A, B and unsmoothed), the mean AUC (with 95%
empirical confidence intervals (C.I.)) were computed by simulating
plausible AUC values from the uncertainty interval for the three
training-test period pairs and calculating the mean of these.
Identification of high-risk areas
In order to produce smoothed estimates of the underlying
snakebite risk in a district, that would be less affected by random
noise, and thereby able to more precisely identify the need for
antivenom accessibility in that district in the upcoming years, the
above model was applied to the most recently available 5-year-
period of the snakebite data; i.e. 2003–2007. After reaching
convergence after 50,000 iterations, the model was run for another
50,000 iterations, during which the probability that the smoothed
incidence exceeded the threshold of 30 bites per 100,000
inhabitants was calculated (Figure 2).
The incidence threshold exceedance probability estimate that
corresponded to 90% sensitivity in detecting districts with an
incidence above the 30 bites per 100,000 inhabitants threshold in a
future 5-year period was on average 10% for three earlier 5-year
periods (data not shown). Therefore, this was set as the cut-off
probability for identifying high-risk districts, in need of good
antivenom accessibility. Rural population residing in an environ-
ment suitable for the medically most relevant snake species B. asper
(i.e. below 1200 meters of elevation and in Moist, Wet or Pluvial
biotic unit [16,28,29]) (Figure 3) were also identified as living in
high-risk areas (Figure 4).
Identification of high-risk areas in need of improved
treatment accessibility
The mountainous terrain of Costa Rica imposes strong
restrictions on human movement. The Euclidean distance (straight
line) approximation of the time needed to move from the place of
snakebite to the healthcare facility (hospital or clinic) might
therefore not accurately capture the real time spent in this
transportation. We aimed at constructing a model of the time
Mapping Snakebite Treatment Accessibility Needs
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needed to reach antivenom treatment, i.e. hospitals or clinics,
which takes into account the availability and quality of roads,
topography, land cover and the mode of transportation used to
reach healthcare. We assumed that people would choose
ambulance services after a snakebite accident. Travel time was
therefore calculated as time with ambulance from closest
ambulance station, to place of residence, and from there to closest
hospital or clinic. The time estimated should be considered a
minimum, ideal, time as it is modeled assuming that the
ambulance leaves immediately after the snakebite to meet up the
snakebite victim, without any delays.
The time to treatment was estimated using GRASS 6.4.1 [36].
The road data vector layer was converted to a 30630 m raster and
classified according to the following assumed speeds: primary
roads, 60 km/h; secondary and urban roads, 40 km/h; and
tertiary, local and other roads, 20 km/h. Off-road speed was set to
6 km/h, but the off-road speed will become 3 km/h as this
distance is not covered by ambulance transportation and it will be
counted twice (see below). Off-road speed in areas covered by
forest was assumed to be 50% slower. Streams, rivers and lakes,
that were not crossed by roads, were given a speed one fifth of that
in open terrain, in order to penalize movement across water. From
the elevation raster, a slope raster was constructed. The road/off-
road speed raster, and the slope raster were combined to yield a
raster of the time needed to travel one raster cell (tr,a) using
Equation 1.
tr,!~tr|
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1z tan !ð Þ
p
zbrz!
2 ðEquation1Þ
The first part (
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1ztan !ð Þp ) of Equation 1 calculates the excess
distance needed to travel the cell due to change in altitude (i.e. the
hypotenuse). The second part (br !2)of the equation aims at
Figure 2. The probability that the smoothed incidence exceeded 30 bites per 100,000 inhabitants in 2003–2007. Inc = incidence.
doi:10.1371/journal.pntd.0002009.g002
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taking into account the reduced speed associated with moving in
undulated terrain, as well as to create barriers in extremely steep
slopes. In this part of the equation, we assume that the excess time
needed to travel one of the 30 m cells is proportional to the
squared slope ! (in degrees) multiplied by a coefficient br (0.001
for road travel and 0.02 for off-road). The value of this co-efficient
was chosen based on simulation of what values produced
reasonable estimations.
The time needed to go from an ambulance station to any cell,
and the time to go from a hospital or clinic to any cell was
calculated. These two time rasters were then summed to give a
raster of the total time needed to reach healthcare facilities using
ambulance, i.e. from ambulance station to snakebite victim and
from there to healthcare (Figure 5). The mean time to reach
healthcare (Figure 5) from populated areas in a high risk of
snakebites (Figure 4) was extracted, and categorized into ,2 h,
2–3 h and .3 h, in order to visualize the need of improved
antivenom accessibility (Figure 6). Finally, the location of EBAIS
and roads were added to the map of populations in need of
improved antivenom accessibility, to develop small-scale maps of
areas in need of improved accessibility to antivenom, which can be
used to guide such improvements (Figure 7 and Supporting
Information S1).
Results
The non-spatial descriptive statistics of major parts of our
dataset correspond very closely to what has been described in
detail previously [14], and thus only a brief summary is presented
in this article. A total of 9,333 cases were reported for the period
1990–2007, corresponding to an average incidence of 13.8
snakebites per 100,000 inhabitants per year. Seventy-two percent
Figure 3. Geographical extent of habitat suitable for Bothrops asper and location of specimens collected at ICP. ICP = Instituto
Clodomiro Picado.
doi:10.1371/journal.pntd.0002009.g003
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of the victims were male. Regarding age, 27% of victims were
below 15 years of age, 32% between 15 and 30 years, 21%
between 30 and 45 years, and the remaining 22% corresponded to
people older than 45 years.
District-level risk factors of snakebites
In multivariate analysis, lowland districts with much precipita-
tion and few dry months generally had a higher snakebite
incidence, as did districts with many rural inhabitants, and many
inhabitants residing close to larger forests, although the last
explanatory factor did not reach 95% significance (Table 1).
Demonstration of spatial smoothing of small-area
snakebite incidence data
The unsmoothed incidence observed in a one-year period had
an acceptable ability to identify which districts would have a high
snakebite incidence in the next five-year period (Table 2), but
discriminatory ability was clearly improved by using smoothing.
There were only minor differences between the estimates
produced by the different smoothing methods A and B in
discriminatory performance. When the training time was only
one the incidence threshold exceedance probability of method A
had a tendency to be better than the smoothed incidence
produced by method B (p = 0.07). When the training time was
five years, both methods had a borderline significantly better
discriminatory ability than the unsmoothed incidence observed in
five years (p = 0.02 for method A and p = 0.10 for method B).
Identification of high-risk districts
There were marked geographical differences in the reported
incidence, with high rates especially along the southern Pacific
coast, and in parts of the Caribbean and northern lowlands
Figure 4. Populated areas in high risk of snakebites. Populated areas = areas within 2 km from a census tract centroid in a high risk of
snakebites, i.e. in districts with a high snakebite incidence, and/or in an area suitable for B. asper.
doi:10.1371/journal.pntd.0002009.g004
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(Figure 1). The districts with a high incidence corresponded to
a large extent to the humid lowland areas identified as suitable
habitat for B. asper (Figure 4); 91% of the rural population in
high-incidence districts lived in this type of environment.
However, only 51% of the rural population in humid lowland
areas lived in districts with a high snakebite incidence. According
to the population distribution of the 2000 census, 18% of the total
population lived in districts with a high snakebite incidence and an
additional 13% lived in rural, humid lowlands in districts not
reporting an incidence above the threshold.
Identification of high-risk areas in need of improved
treatment accessibility
Hospitals, clinics, ambulance stations and roads were strongly
aggregated in the great metropolitan area around the cities of
San Jose´, Heredia, Cartago and Alajuela, where a major part
Figure 5. Clinics, hospitals, ambulance stations and estimated time to hospital or clinic.
doi:10.1371/journal.pntd.0002009.g005
Table 1. District-level risk factors for snakebite incidence in
multivariate Poisson regression.
Covariate Unit
Incidence
Ratio
95%
Cr.I.
Low
95%
Cr.I.
High
Elevation +550 m 0.60 0.48 0.75
Dry months +1.25 months 0.66 0.51 0.86
Precipitation +827 mm/year 1.45 1.13 1.80
Population living within
500 m from .5 ha forest
+100%-units 1.53 0.88 2.59
Urban population +100%-units 0.39 0.29 0.53
doi:10.1371/journal.pntd.0002009.t001
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of the population lives. There is however also a network of roads
and healthcare facilities in the more peripheral regions of the
country (Figure 5). Of the population living in areas with a high
risk of snakebites, 92.5% were estimated to have a minimum
transportation time of less than 2 hour to hospitals or clinics, 5%
were estimated to delay 2–3 hours to hospitals or clinics, and 2.5%
more have transportation times higher than 3 hours. On the south
Pacific coast around Golfo Dulce, around the Talamanca
highlands in the southeast, and along the northern border, there
are populations in high risk of snakebites and with long
transportation times to antivenom treatment (Figure 6). Figure 7
provides a close-up view of one target region (Golfo Dulce),
including all the information presented in the previous maps, as
well as the location of primary health care facilities (EBAIS). This
map demonstrates the type of map that can be prepared and used
to identify vulnerable places where access to hospitals or clinics is
delayed, thus setting the stage for the design of more effective ways
to guarantee a more rapid access to antivenom treatment at the
local level. Similar maps for other target regions are available as a
supplement (Supporting Information S1).
Discussion
Key results
The spatial distribution of district-level snakebite incidence in
Costa Rica largely followed the expected pattern, based on
previous studies and on the distribution of the most important
venomous snake in the country, B. asper. Incidence was higher in
rural, humid lowlands, notably in the southern part of the country
[14]. Geographical accessibility to antivenom treatment was
Figure 6. Time to hospital or clinic for populated areas at high risk of snakebites. Populated areas = areas within 2 km from a census tract
centroid in a high risk of snakebites.
doi:10.1371/journal.pntd.0002009.g006
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generally good, however, in some areas there is a need of
improved treatment accessibility. These are areas where hospitals
and clinics are located relatively far from some of the areas with a
likely high snakebite incidence.
Limitations
The potential bias introduced by using data reported from the
healthcare system to analyze snakebite incidence, due to the use of
traditional medicine and dysfunctional reporting routines, are well
known from other parts of the world [9,37]. However, in contrast
to the situation in many other developing countries in Latin
America and elsewhere, traditional medicine is not widely used in
Costa Rica [38] and the formal health care system is well
developed and largely accessible [23]. The percentage of births
attended by skilled personnel was 98.7% in 2007 [39], highlighting
a highly developed and utilized formal healthcare system. A survey
among snakebite victims receiving treatment at hospitals in 1996
found that only 2.9% of them had received any type of empirical
treatment before reaching formal healthcare attention [19]. The
literacy rate in Costa Rica is 96% [39], and educational campaigns
of various sorts over several decades have raised awareness about
the importance of seeking formal healthcare after snakebites
among the Costa Rican public [19]. Based on these facts, we
assume that the degree of utilization of traditional healthcare after
snakebites is very low in Costa Rica and that, on this basis, there
will not be much underestimation of the true snakebite incidence
in the statistics available from the Ministry of Health. Nevertheless,
our data may still suffer from under- or misreporting because of
reporting errors, such as missing discharge reports.
Assuming equal distribution of snakebite risk within districts is a
strong assumption. Even if districts are the smallest administrative
unit, several spatial processes could still lead to large incidence
Figure 7. Close-up view of the Golfo Dulce region. Time to reach hospital or clinic for populated areas with a high snakebite risk, health care
facilities and roads. Populated areas = areas within 2 km from a census tract centroid in a high risk of snakebites.
doi:10.1371/journal.pntd.0002009.g007
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variations within districts. One specific example of where problems
are likely to arise due to within-district variation is in districts with
high proportion of urban residents. Even though snakebite
incidence might be high among the rural population of such
districts, this might go unnoticed due to the large urban population
among which there are few snakebites. By mapping census
enumeration units with risk factors favoring snakebite occurrence,
the impact of the above two limitations can be reduced as this risk-
factor based approach is not dependent on the quality of the
gathered incidence data or arbitrary district divisions.
The information about the location of the health care system
must be regarded with caution; previous centrally available
information about primary health care facilities has been found
incorrect in an earlier study [23]. Furthermore, the method of
locating primary health care facilities (EBAIS) by matching facility
and community names is not infallible as there was not always a
community with the same name as the EBAIS. However, this was
mostly a problem in the urban areas, and thus of smaller
importance for this study. The data about roads was generally old,
and as there has likely been some improvement in road
availability and quality since the data was gathered, our estimates
of the time needed to reach treatment might be biased towards
overestimation.
The estimated transportation times to reach hospital or clinic
were much lower than those observed in previous studies of the
time to hospital treatment of snakebites in Costa Rica. In a
hospital-based study of all snakebites in 1996 [19], the time to
reach hospital was recorded for approximately 70% of the
patients. Of these, 61% reached hospital within 3 hours and
20% after more than 5 hours. However, the estimates cannot be
fully compared with the transportation times observed in this study
as they were recorded at hospitals, meaning that a major
proportion of the patients could have received antivenom
treatment at clinics and subsequently been transferred to a
hospital, something that would delay the time to reach hospital
substantially. Saborio et al. [40] found that among children
admitted to the hospital in Limon on the Caribbean coast in
1985–1995, 50% received medical treatment within 3 hours,
whereas the mean time was 6.8 hours, indicating very long
transportation times for some snakebite victims in this area, parts
of which are also estimated to have long times to treatment by our
model. Another reason why it could be incorrect to compare the
estimated times with the time observed in these studies is that they
are at least 15 years old, and there have been improvements in
ambulance and health care facility accessibility, telecommunica-
tions, and possibly road network since then. It should however be
further emphasized that our model aim at estimating the ideal
time to reach treatment, and that in reality there could be several
unaccounted-for causes of longer times, such as problems in
communicating with ambulance stations, temporarily impassable
roads or unavailable ambulance services, etc. Even though there is
a discrepancy between the estimated and observed times to
treatment, we consider that the time-to-treatment estimation
model provides important hints about the location of areas where
the accessibility to antivenom treatment is more difficult. If the
minimum time to treatment is estimated to be 2 hours in our
analysis, there is an imperative for improved accessibility as the
actual time to treatment will probably be longer.
It is however important to remember that healthcare accessi-
bility cannot be reduced to a purely spatial concern. Logistical
issues, such as effective communication with ambulance facilities,
availability of ambulances, and problems with other forms of
transportation in the communities need to be taken into account as
well. Furthermore, geographical accessibility is just one dimension
of health care access [41]; economic, social and cultural
dimensions need to be also considered, something that is easily
missed when doing analyses based on maps only. Research
gathering empirical evidence on the actual, current time needed to
reach treatment, and determinants of this time, would provide
important information for the identification of vulnerable regions
and for improving access to snakebite treatment in Costa Rica.
Interpretation
The estimated minimum times to reach antivenom treatment
were generally short, compared to the actual times to reach health
facilities after snakebites reported in previous studies in Costa Rica
[19,40]. However, our analysis allowed the identification of some
areas where accessibility to antivenom treatment needs to be
improved. The specific strategies to be implemented to accomplish
this demand a case by case analysis on a local basis, but a feasible
alternative might be the distribution of antivenoms to some
EBAIS, the strengthening of the training of health staff in
antivenom use, and the organization of the work in such a way
that antivenom is available at all times. There is a risk of over-
interpreting the messages transmitted through these maps and
forget how sensitive it is to data errors and assumptions of, for
example, road speeds. Based on these limitations, we advise that
the maps should be interpreted with care, and that the expert
knowledge of actual conditions provided by health care officials at
a local level is also taken into account when making decisions
about allocation of treatment resources.
Generalizability
The snakebite incidence data available in this study, country-
wide, based on the smallest administrative unit and probably
reliable, are not available in many of the countries where this type
of study needs to be conducted, owing to the large underestimation
of snakebite incidence and mortality by hospital statistics
[37,42,43]. For data available as small area counts, Bayesian
smoothing techniques have a well-known ability to improve
interpretability [26], as further demonstrated in this study. Thus,
using Bayesian smoothing, the interpretability of the gathered data
can be increased so that more accurate estimations of area-level
incidence can be made from sparse data. Leynaud and Reati [21]
used a spatial Bayesian smoothing technique available in SIGEpi
Table 2.Mean discriminatory abilities of the estimates
produced by the two smoothing methods (A and B) for the
two training time lengths (1 and 5 years).
Test statistic 95% Empirical C.I.
Trainingtime
(years)
Smoothingmet-
hod
mean
AUC Low High
1 None 0.83 0.79 0.86
5 None 0.93 0.91 0.95
1 A 0.95 0.93 0.96
5 A 0.96 0.95 0.97
1 B 0.93 0.91 0.95
5 B 0.96 0.94 0.97
A. The smoothed incidence exceedance probability estimate obtained from the
Bayesian Poisson regression model with spatially correlated random effects and
fixed effect explanatory variables, described in Methods section. B. The
smoothed incidence estimate obtained from the built-in Bayesian spatial
smoothing tool ‘‘Suavizador espacial de tasas’’ in SIGEpi [22].
doi:10.1371/journal.pntd.0002009.t002
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[22]. We compared this technique with a Bayesian smoothing
technique that also allowed for variation in district risk factor
composition, and enabled estimation of the probability that an
incidence threshold value was exceeded. We found that there were
benefits of employing such smoothing techniques to improve the
interpretability of the raw incidence when the data material was
sparse, whereas there was no significant difference when the data
material was increased (in this case five years of observation time
instead of one year).
Large-scale approaches to identifying areas in need of
antivenom could also benefit from using GIS. Available house-
hold-based incidence surveys, hospital and mortality records etc.,
could be mapped and used to construct geostatistical models
which, based on the spatial variation of snakebite burden and its
relationship with other spatially varying factors, predict snakebite
burden in areas for which there is no data available. By taking this
spatial approach, the sparse data available could be better utilised
than predicting snakebite burden in non-surveyed areas by
extrapolating information to country or Global Burden of Disease
Region, as was the method used in the most recent review of
global snakebite burden [1]. There has been an attempt to use
such methods to map snakebite in West Africa [10], and useful
methods have been further developed in studies predicting burden
of other tropical diseases, such as soil-transmitted helminth
infection [44] and malaria [45]. However, in order for these
approaches to be feasible, there is still a large need for more data
on snakebite burden, especially in sub-Saharan Africa, where a
recent systematical review found only a small number of studies
[46]. Large-scale studies such as those recently conducted to
estimate snakebite mortality and incidence in India [43] and
Bangladesh [37], respectively, provide an important source of data
for producing snakebite burden maps, especially if the geograph-
ical coordinates of the survey clusters are available.
Mapping the availability of treatment is another challenge to
implementing our method on a large scale; antivenom availability
in many areas of low income countries is known to be poor [3], but
information on antivenom availability on facility or even country
level is to our knowledge not easily available, but requires further
data collection.
GIS not only offers the possibility to improve the interpretation
of incidence data through spatial smoothing, but also to identify
areas which, on the basis of environmental risk factors, could be
expected to have a high snakebite incidence. This approach could
be especially useful when incidence data are considered unreliable.
We compared the map of areas with an environment considered as
suitable habitat for Bothrops asper, with a map of specimen
collection locations, and found that these had good congruence,
except for the Nicoya Peninsula, where environmental degrada-
tion could have led to species disappearance [17]. The method of
determining high-risk areas by environmental determinants
requires prior knowledge about the habitat of the snake species
and should ideally be complemented by such field studies of actual
snake distribution. Another important application of GIS in the
struggle for reducing the impact of snakebite envenoming is the
ability to analyze geographical accessibility to treatment, an
important factor for the outcome of the bite. Leynaud and Reati
[21] used Euclidean distances to hospitals and roads to analyze
access to treatment, a common and readily implemented choice.
We used a more demanding method aiming at estimating the time
required for a snakebite victim to reach healthcare that takes into
account topography, land use, road type and location of
ambulance services. This theoretically allows for a more detailed
analysis of the time needed to reach treatment, especially in
mountainous study areas.
Our study demonstrates that using GIS it is possible to facilitate
rational decision-making on localization of treatment resources
against snakebite by overlaying the risk of snakebite accidents,
estimated using reported data and/or presence of risk factors,
transport times to existing hospitals or clinics, and the location of
possible additional facilities to which treatment resources could be
allocated. GIS is a promising tool for devising cost-effective
interventions aimed at reducing the public health impact of
snakebite envenoming.
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